SAB4200346
Anti-SMAD7 (N-terminal) antibody produced in rabbit
~1.0 mg/mL, affinity isolated antibody, suitable for western blot: 2 μg/mL
同義詞:
Anti-CRCS3, Anti-MAD homolog 7, Anti-MAD homolog 8, Anti-MADH7, Anti-MADH8, Anti-Mothers against DPP homolog 7, Anti-Mothers against DPP homolog 8, Anti-SMAD
登入查看組織和合約定價
全部照片(2)
About This Item
推薦產品
生物源
rabbit
品質等級
共軛
unconjugated
抗體表格
affinity isolated antibody
抗體產品種類
primary antibodies
無性繁殖
polyclonal
形狀
buffered aqueous solution
分子量
antigen ~46 kDa
物種活性
human
濃度
~1.0 mg/mL
技術
indirect immunofluorescence: 1-2 μg/mL using human A549 cells.
western blot: 2-4 μg/mL using whole extracts of HEK-293 cells over-expressing human SMAD7.
UniProt登錄號
運輸包裝
dry ice
儲存溫度
−20°C
目標翻譯後修改
unmodified
基因資訊
human ... SMAD7(4092)
一般說明
SMAD7 (mothers against decapentaplegic homolog 7) is a Tbx1 (T-box 1) interacting gene and is encoded by the gene mapped to human chromosome 18q21.1.
SMAD7 (mothers against decapentaplegic homolog 7), that binds the E3 ubiquitin ligase Smurf1/2. SMAD7 belongs to the family of inhibitory Smads (I-Smads).
免疫原
peptide corresponding to the N-terminal region of human SMAD7, conjugated to KLH. The corresponding sequence is identical in monkey and differs by 2 amino acids in mouse and rat.
應用
Anti-SMAD7 (N-terminal) antibody produced in rabbit has been used in immunoblotting and immunofluorescence.
生化/生理作用
SMAD7 (mothers against decapentaplegic homolog 7) is a modulator of TGFβ (transforming growth factor β) signaling in immune cells which are associated with ulcerative colitis and inflammatory bowel syndrome. It plays a major role in the etiology of CRC (colorectal cancer). In addition, it also acts as a mediator of the negative feedback loop for both the TGFβ and BMP (bone morphogenetic proteins) signaling pathways. It is essential for the remodelling of pharyngeal artery and the enlargement of great vessel. In mouse, homozygous removal of Smad7 causes primarily fourth-related arch artery defects. Silencing of Smad7 in RCD (refractory coeliac disease) biopsy samples can decrease the expression of interleukin-6 and tumour necrosis factor-α. Polymorphism of this gene is associated with colorectal cancer. SMAD7 is an inhibitor of the TGFβ (transforming growth factor beta) /BMP (bone morphogenetic proteins) pathway.
外觀
Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.
免責聲明
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到適合的產品?
試用我們的產品選擇工具.
儲存類別代碼
10 - Combustible liquids
閃點(°F)
Not applicable
閃點(°C)
Not applicable
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。
Smad7: not only a regulator, but also a cross-talk mediator of TGF-beta signalling
The Biochemical Journal, 434(1), 1-10 (2011)
Multiple functional risk variants in a SMAD7 enhancer implicate a colorectal cancer risk haplotype.
PLoS ONE, 9 (2014)
EBioMedicine, 62, 103108-103108 (2020-11-14)
Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, with unmet need for the pharmacological therapy. The functions of ATXN7L3 in HCC progression are not known. RNA sequence, quantitative real-time PCR, and western blot were performed to detect
High Smad7 sustains inflammatory cytokine response in refractory coeliac disease.
Immunology, 150, 356-363 (2017)
Intronic polymorphisms of the SMAD7 gene in association with colorectal cancer.
Asian Pacific Journal of Cancer Prevention, 16, 41-44 (2015)
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務